KPRX
Kiora Pharmaceuticals, Inc. Common Stock
stockNASDAQ
traded on nasdaq capital market, stock symbol eyeg, eyegate is a clinical-stage specialty pharmaceutical company that develops and commercializes products using two proprietary platform technologies for treating diseases and disorders of the eye. our most advanced platform is based on a crosslinked thiolated carboxymethyl hyaluronic acid ("cmha-s"), a modified form of the natural polymer hyaluronic acid ("ha"), which is a gel that possesses unique physical and chemical properties such as hydrating and healing when applied to the ocular surface. our first cmha-s-based product candidate, the eyegate ocular bandage gel ("obg"), is a topically applied eye drop formulation that has completed its first-in-man clinical trial for the healing and lubricating of large epithelial defects following treatment after photorefractive keratectomy ("prk") surgery. our initial product candidate from our second platform is egp-437, incorporates a reformulated topically active corticosteroid, dexamethasone
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.32 | 2026-10-22 | -21.74% | 0.939 |
| 1M | 2.60 | 2026-09-29 | -30.17% | 0.025 |
| 3M | 2.57 | 2026-07-29 | -29.35% | -0.226 |
| 6M | 2.35 | 2026-04-29 | -22.74% | -0.055 |
| 1Y | 2.53 | 2025-10-29 | -28.24% | 0.924 |
| 2Y | 3.85 | 2024-10-29 | -52.84% | — |
| 5Y | 684.00 | 2021-10-29 | -99.73% | 0.867 |
Kiora Pharmaceuticals, Inc. Common Stock (NASDAQ:KPRX) stock price today is $1.82, and today's volume is 365,503. KPRX is down 23.068% today. The 30 day average volume is 15,186. KPRX market cap is $8.03M with 4.42M shares outstanding.